Non-Markov Multistate Modeling Using Time-Varying Covariates, with Application to Progression of Liver Fibrosis due to Hepatitis C Following Liver Transplant

Multistate modeling methods are well-suited for analysis of some chronic diseases that move through distinct stages. The memoryless or Markov assumptions typically made, however, may be suspect for some diseases, such as hepatitis C, where there is interest in whether prognosis depends on history. This paper describes methods for multistate modeling where transition risk can depend on any property of past progression history, including time spent in the current stage and the time taken to reach the current stage. Analysis of 901 measurements of fibrosis in 401 patients following liver transplantation found decreasing risk of progression as time in the current stage increased, even when controlled for several fixed covariates. Longer time to reach the current stage did not appear associated with lower progression risk. Analysis of simulation scenarios based on the transplant study showed that greater misclassification of fibrosis produced more technical difficulties in fitting the models and poorer estimation of covariate effects than did less misclassification or error-free fibrosis measurement. The higher risk of progression when less time has been spent in the current stage could be due to varying disease activity over time, with recent progression indicating an "active" period and consequent higher risk of further progression.

[1]  A. Valleron,et al.  Quantification of fibrosis progression in patients with chronic hepatitis C using a Markov model , 2002, Journal of viral hepatitis.

[2]  P. Bedossa,et al.  Natural history of liver fibrosis progression in patients with chronic hepatitis C , 1997, The Lancet.

[3]  T. Cross,et al.  Non‐invasive markers for the prediction of fibrosis in chronic hepatitis C infection , 2008, Hepatology research : the official journal of the Japan Society of Hepatology.

[4]  T. O'Brien,et al.  Estimating past hepatitis C infection risk from reported risk factor histories: implications for imputing age of infection and modeling fibrosis progression , 2007, BMC infectious diseases.

[5]  P. Bacchetti,et al.  Estimating Complex Multi-State Misclassification Rates for Biopsy-Measured Liver Fibrosis in Patients with Hepatitis C , 2009, The international journal of biostatistics.

[6]  Bryan Lau,et al.  Exceeding the limits of liver histology markers. , 2009, Journal of hepatology.

[7]  H. Allore,et al.  A Semiparametric Transition Model with Latent Traits for Longitudinal Multistate Data , 2008, Biometrics.

[8]  R. Fontana,et al.  Fibrosis progression in African Americans and Caucasian Americans with chronic hepatitis C. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[9]  J. Hoofnagle,et al.  Classification of chronic hepatitis: Diagnosis, grading and staging , 1994, Hepatology.

[10]  N. Afdhal,et al.  Diagnosis and quantitation of fibrosis. , 2008, Gastroenterology.

[11]  Simon G. Thompson,et al.  Multistate Markov models for disease progression with classification error , 2003 .

[12]  Christopher H Jackson,et al.  Hidden Markov models for the onset and progression of bronchiolitis obliterans syndrome in lung transplant recipients , 2002, Statistics in medicine.

[13]  L. Ferrell,et al.  HCV-related fibrosis progression following liver transplantation: increase in recent years. , 2000, Journal of hepatology.